Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Capricor Therap (NQ: CAPR )

3.980 USD -0.030 (-0.75%)
Official Closing Price Updated: 5:28 PM EDT, Apr 19, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 254,900
Open 4.030
Bid (Size) 3.890 (1)
Ask (Size) 4.000 (13)
Prev. Close 4.010
Today's Range 3.862 - 4.070
52wk Range 1.600 - 12.32
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Capricor Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
From GlobeNewswire News Releases
Capricor Therapeutics Announces New Advances in Exosome-Mediated mRNA Delivery Platform
From GlobeNewswire News Releases

Performance

YTD
+6.42%
+6.42%
1 Month
-24.62%
-24.62%
3 Month
-26.84%
-26.84%
6 Month
-14.04%
-14.04%
1 Year
+135.50%
+135.50%

More News

Read More
Capricor Therapeutics to Present Fourth Quarter and Full Year 2020 Financial Results and Recent Corporate Update on March 11
From GlobeNewswire News Releases
Capricor Therapeutics Announces Development of Serology Test to Confirm Activity of SARS-CoV-2 Vaccines
From GlobeNewswire News Releases
Capricor Therapeutics Announces Publication Demonstrating Methods for Enhanced Potency of Cardiosphere-Derived Exosomes
From GlobeNewswire News Releases
BioMedNewsBreaks – Capricor Therapeutics Inc. (NASDAQ: CAPR) Featured by M-Vest
From InvestorBrandNetwork
12 Health Care Stocks Moving In Friday's Pre-Market Session
Tags MNOV Movers CFRX
From Benzinga
Capricor Collaborates with Lonza for the Development of CAP-1002, its Cell Therapy Candidate for the Treatment of Duchenne Muscular Dystrophy and Other Indications
From GlobeNewswire News Releases
12 Health Care Stocks Moving In Tuesday's Intraday Session
Tags Markets CAPR Intraday Update
From Benzinga
The Daily Biotech Pulse: Novavax Vaccine Data, ContraFect Secures BARDA Funding, 2 IPOs
Tags ABBV BOLT BMY
From Benzinga
The Daily Biotech Pulse: Contrasting COVID-19 Treatment Readouts From Roche, Vir, Delay In Kadmon's FDA Review, Alzheimer's Data From Prothena
Tags NARI BNR TFFP
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.